Cargando…
Use of a Clostridioides difficile Murine Immunization and Challenge Model to Evaluate Single and Combination Vaccine Adjuvants Consisting of Alum and NKT Cell-Activating Ligands
Adjuvant combinations may enhance or broaden the expression of immune responses to vaccine antigens. Information on whether established Alum type adjuvants can be combined with experimental CD1d ligand adjuvants is currently lacking. In this study, we used a murine Clostridioides difficile immunizat...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8794951/ https://www.ncbi.nlm.nih.gov/pubmed/35095921 http://dx.doi.org/10.3389/fimmu.2021.818734 |
_version_ | 1784640939460919296 |
---|---|
author | Lang, Gillian A. Norman, Kaylee Amadou Amani, Souwelimatou Shadid, Tyler M. Ballard, Jimmy D. Lang, Mark L. |
author_facet | Lang, Gillian A. Norman, Kaylee Amadou Amani, Souwelimatou Shadid, Tyler M. Ballard, Jimmy D. Lang, Mark L. |
author_sort | Lang, Gillian A. |
collection | PubMed |
description | Adjuvant combinations may enhance or broaden the expression of immune responses to vaccine antigens. Information on whether established Alum type adjuvants can be combined with experimental CD1d ligand adjuvants is currently lacking. In this study, we used a murine Clostridioides difficile immunization and challenge model to evaluate Alum (Alhydrogel™), α-galactosylceramide (α-GC), and one of its analogs 7DW8-5 singly and in combination as vaccine adjuvants. We observed that the Alum/α-GC combination caused modest enhancement of vaccine antigen-specific IgG1 and IgG2b responses, and a broadening to include IgG2c that did not significantly impact overall protection. Similar observations were made using the Alum/7DW8-5 combination. Examination of the impact of adjuvants on NKT cells revealed expansion of invariant NKT (iNKT) cells with modest expansion of their iNKTfh subset and little effect on diverse NKT (dNKT) cells. Side effects of the adjuvants was determined and revealed transient hepatotoxicity when Alum/α-GC was used in combination but not singly. In summary these results showed that the Alum/α-GC or the Alum/7DW8-5 combination could exert distinct effects on the NKT cell compartment and on isotype switch to produce Th1-driven IgG subclasses in addition to Alum/Th2-driven subclasses. While Alum alone was efficacious in stimulating IgG-mediated protection, and α-GC offered no apparent additional benefit in the C. difficile challenge model, the work herein reveals immune response features that could be optimized and harnessed in other vaccine contexts. |
format | Online Article Text |
id | pubmed-8794951 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-87949512022-01-29 Use of a Clostridioides difficile Murine Immunization and Challenge Model to Evaluate Single and Combination Vaccine Adjuvants Consisting of Alum and NKT Cell-Activating Ligands Lang, Gillian A. Norman, Kaylee Amadou Amani, Souwelimatou Shadid, Tyler M. Ballard, Jimmy D. Lang, Mark L. Front Immunol Immunology Adjuvant combinations may enhance or broaden the expression of immune responses to vaccine antigens. Information on whether established Alum type adjuvants can be combined with experimental CD1d ligand adjuvants is currently lacking. In this study, we used a murine Clostridioides difficile immunization and challenge model to evaluate Alum (Alhydrogel™), α-galactosylceramide (α-GC), and one of its analogs 7DW8-5 singly and in combination as vaccine adjuvants. We observed that the Alum/α-GC combination caused modest enhancement of vaccine antigen-specific IgG1 and IgG2b responses, and a broadening to include IgG2c that did not significantly impact overall protection. Similar observations were made using the Alum/7DW8-5 combination. Examination of the impact of adjuvants on NKT cells revealed expansion of invariant NKT (iNKT) cells with modest expansion of their iNKTfh subset and little effect on diverse NKT (dNKT) cells. Side effects of the adjuvants was determined and revealed transient hepatotoxicity when Alum/α-GC was used in combination but not singly. In summary these results showed that the Alum/α-GC or the Alum/7DW8-5 combination could exert distinct effects on the NKT cell compartment and on isotype switch to produce Th1-driven IgG subclasses in addition to Alum/Th2-driven subclasses. While Alum alone was efficacious in stimulating IgG-mediated protection, and α-GC offered no apparent additional benefit in the C. difficile challenge model, the work herein reveals immune response features that could be optimized and harnessed in other vaccine contexts. Frontiers Media S.A. 2022-01-14 /pmc/articles/PMC8794951/ /pubmed/35095921 http://dx.doi.org/10.3389/fimmu.2021.818734 Text en Copyright © 2022 Lang, Norman, Amadou Amani, Shadid, Ballard and Lang https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Immunology Lang, Gillian A. Norman, Kaylee Amadou Amani, Souwelimatou Shadid, Tyler M. Ballard, Jimmy D. Lang, Mark L. Use of a Clostridioides difficile Murine Immunization and Challenge Model to Evaluate Single and Combination Vaccine Adjuvants Consisting of Alum and NKT Cell-Activating Ligands |
title | Use of a Clostridioides difficile Murine Immunization and Challenge Model to Evaluate Single and Combination Vaccine Adjuvants Consisting of Alum and NKT Cell-Activating Ligands |
title_full | Use of a Clostridioides difficile Murine Immunization and Challenge Model to Evaluate Single and Combination Vaccine Adjuvants Consisting of Alum and NKT Cell-Activating Ligands |
title_fullStr | Use of a Clostridioides difficile Murine Immunization and Challenge Model to Evaluate Single and Combination Vaccine Adjuvants Consisting of Alum and NKT Cell-Activating Ligands |
title_full_unstemmed | Use of a Clostridioides difficile Murine Immunization and Challenge Model to Evaluate Single and Combination Vaccine Adjuvants Consisting of Alum and NKT Cell-Activating Ligands |
title_short | Use of a Clostridioides difficile Murine Immunization and Challenge Model to Evaluate Single and Combination Vaccine Adjuvants Consisting of Alum and NKT Cell-Activating Ligands |
title_sort | use of a clostridioides difficile murine immunization and challenge model to evaluate single and combination vaccine adjuvants consisting of alum and nkt cell-activating ligands |
topic | Immunology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8794951/ https://www.ncbi.nlm.nih.gov/pubmed/35095921 http://dx.doi.org/10.3389/fimmu.2021.818734 |
work_keys_str_mv | AT langgilliana useofaclostridioidesdifficilemurineimmunizationandchallengemodeltoevaluatesingleandcombinationvaccineadjuvantsconsistingofalumandnktcellactivatingligands AT normankaylee useofaclostridioidesdifficilemurineimmunizationandchallengemodeltoevaluatesingleandcombinationvaccineadjuvantsconsistingofalumandnktcellactivatingligands AT amadouamanisouwelimatou useofaclostridioidesdifficilemurineimmunizationandchallengemodeltoevaluatesingleandcombinationvaccineadjuvantsconsistingofalumandnktcellactivatingligands AT shadidtylerm useofaclostridioidesdifficilemurineimmunizationandchallengemodeltoevaluatesingleandcombinationvaccineadjuvantsconsistingofalumandnktcellactivatingligands AT ballardjimmyd useofaclostridioidesdifficilemurineimmunizationandchallengemodeltoevaluatesingleandcombinationvaccineadjuvantsconsistingofalumandnktcellactivatingligands AT langmarkl useofaclostridioidesdifficilemurineimmunizationandchallengemodeltoevaluatesingleandcombinationvaccineadjuvantsconsistingofalumandnktcellactivatingligands |